Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-10T21:07:41.412Z Has data issue: false hasContentIssue false
  • English
  • Français

When You Reach a Fork in the Road, Take it: Science and Product Development as Linked Paths

Published online by Cambridge University Press:  06 January 2021

Gerald T. Keusch
Gerald T. Keusch*
Affiliation:
Global Health, Boston University
Get access Rights & Permissions [Opens in a new window]

Extract

Increasingly, health is recognized as a major force for economic development; and because economic development is central to political and social stability, health is being looked at as the great hope for the future of the world, as population sizes and disparities among them increase. This perspective has been growing ever since the 1993 World Development Report was released by the World Bank, and it has fueled an intensive scrutiny of health care around the world, focusing on systems and health care delivery on the one hand, and equitable access to the products of research on the other hand. In the middle of all of is this is a concern about how health care (which must include both the training of personnel from the basic low level health care worker to the physician), and research and development (which must include the financing of research in academia and the development of products primarily in the private sector) are organized, and how they do or do not address inequities between and within populations and nations.

Type
Article
Information
American Journal of Law & Medicine , Volume 34 , Issue 2-3 , June 2008 , pp. 141 - 149
Copyright
Copyright © American Society of Law, Medicine and Ethics and Boston University 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

Editor's Note: this article is an edited version of the remarks Dr. Keusch made at the symposium.

References

1 S.E. Luria, The Goals of Science, http://profiles.nlm.nih.gov/QL/B/B/H/J/_/qlbbhj.pdf.

2 Zhang, Junfu, A Study of Academic Entrepreneurs Using Venture Capital Data, Institute for the Study of Labor (Bonn, Germany 2007)Google Scholar, available at http://ideas.repec.org/p/iza/izadps/dp2992.html.

3 Global Health Program, Bill & Melinda Gates Foundation, http://www.gatesfoundation.org/GlobalHealth

4 Varmus, Harold, et al., Grand challenges In Global Health, 302 Science 398 (2003)Google Scholar.

5 Bill and Melinda Gates Foundation, Press Release, New Initiative to Spur Innovation in Global Health Research, http://www.gcgh.org/NewsEvents/MediaCenter.

6 International AIDS Vaccine Initiative, http://www.iavi.org.

7 Global Alliance for Tuberculosis Drug Development http://www.tballiance.org/home/home.php

8 Centre for the Management of Intellectual Property in Health Research (MIHR), http://www.mihr.org

9 IP Handbook of Best Practices, http://www.iphandbook.org/handbook.

10 Amy Kapczynski, Yale's Patent Policy Unfit for AIDS Medicines, Yale Daily News, Oct. 19, 2001, available at http://www.yaledailynews.com/articles/view/1965.

11 Social Entrepreneurship Links, http://www.xpdnc.com/links/sntrprnr.html. Social Venture Network, http://www.svn.org ; Bioventures for Global Health, http://www.bvgh.org.

12 Sharon Jayson, Generation Y Gets Involved, USA Today, Oct. 23, 2006, available at http://www.usatoday.com/news/nation/2006-10-23-gen-next-cover_x.htm.